Impact of Improved Diagnosis and Treatment on Holistic CKD Burden
Differences in projected impacts between countries are multifactorial, though they are sensitive to demographics and health care systems. Implementation of policies that lead to improved detection and treatment of CKD are urgently required across the globe to mitigate the growing burdens of CKD on patients and caregivers, health care systems, society, and our environment.
Authors
- Ming‐Hui Zhao (ORCID: https://orcid.org/0000-0003-3340-3108)
- Jieling Chen (ORCID: https://orcid.org/0000-0001-7728-3959)
- Nick Guldemond (ORCID: https://orcid.org/0000-0002-4909-2220)
- Christoph Wanner (ORCID: https://orcid.org/0000-0001-9507-5301)
- Breonny Robson (ORCID: https://orcid.org/0009-0005-3453-817X)
- Anthony Zara (ORCID: https://orcid.org/0000-0002-2723-3563)
- Fiona Adshead
- Matthew J. Eckelman (ORCID: https://orcid.org/0000-0002-0595-3682)
- Steven J. Chadban (ORCID: https://orcid.org/0000-0002-0527-898X)
- Ana Flávia Moura (ORCID: https://orcid.org/0000-0001-7368-4704)
- Ralph Audehm (ORCID: https://orcid.org/0000-0001-9136-8772)
- Navdeep Tangri (ORCID: https://orcid.org/0000-0002-5075-6370)
- Bo Long (ORCID: https://orcid.org/0000-0002-5632-5125)
- Naveen Rao
- Stacey Priest
- Clélia-Elsa Froguel
Institutions
- AstraZeneca (United Kingdom) (GB)
- Northeastern University (US)
- Escola Bahiana de Medicina e Saúde Pública (BR)
- The University of Melbourne (AU)
- Royal Prince Alfred Hospital (AU)
- Leiden University Medical Center (NL)
- Kidney Health Australia (AU)
- Universitätsklinikum Würzburg (DE)
- Centre for Sustainable Healthcare (GB)
- AstraZeneca (United States) (US)
- University of Manitoba (CA)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1016/j.ekir.2025.05.039
- Citations
- 4
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 5.72
Funders
- AstraZeneca
- London School of Economics and Political Science